2013 American Transplant Congress
Prevalence of Metabolic Syndrome in Renal Transplant Patients: Comparison of Two Diagnostic Criteria
Renal Transplantation Service, Hospital das Clinicas - FMUSP, Sao Paulo, Brazil
Metabolic syndrome (MS) is now recognized as a risk factor for cardiovascular disease (CV), the leading cause of death with a functioning graft in renal…2013 American Transplant Congress
Transitions of Care To Reduce Early Readmissions Following Kidney Transplantation
Pharmacy, University of Michigan Health System, Ann Arbor, MI
Background: Hospital readmission became an important metric for measuring quality of patient care. Although transitions of care interventions prevented readmission in various settings, they have…2013 American Transplant Congress
Threatened Kidney Allograft: Use of mTOR- Inhibitor Increases All Cause Mortality
Nephrology, UMMC, Baltimore, MD
Background:Acute allograft dysfunction due to IFTA is often attributed to cumulative exposure to tacrolimus. Can replacement of CNI with m-TOR inhibitor prevent progression in IF/TA…2013 American Transplant Congress
Increasing Living Donor (LD) Kidney Transplants by Streamlining the Evaluation Process
UNC Center for Transplant Care, Chapel Hill; UNC Department of Surgery, Chapel Hill
While the organ waiting list in the US keeps growing, number of donors stays the same increasing the gap between recipients and donors. One of…2013 American Transplant Congress
Levothyroxine Therapy Prior to Brain Death Declaration Increases the Number of Solid Organ Donations
Department of Surgery, The University of Arizona, Tucson, AZ
INTRODUCTION: Protocols call for the start of hormonal therapy with Levothyroxine after declaration of brain death. As the hormonal perturbations occur during the process of…2013 American Transplant Congress
Adjunctive Bortezomib Therapy for Treatment of Antibody Mediated Rejection in Kidney Transplant Recipients
Transplant Med, NYPH-Weill Cornell
Background: Antibody mediated rejection (AMR) is associated with poor graft survival. Targeted treatment with bortezomib has been shown to reduce donor specific antibodies (DSA), but…2013 American Transplant Congress
Associations of Nephrosclerosis with Kidney Function and Size in Living Kidney Donors (LKD)
Despite their selection on health, LKD have been found to have subclinical nephrosclerosis. Identifying pre-donation characteristics that predict nephrosclerosis is of critical importance. We evaluated…2013 American Transplant Congress
Residual Renal Function in Living Kidney Donors: Does Remaining Kidney Volume Matter?
Ohio State University, Columbus; IUH Transplant, Indiana University Health, Indianapolis
Background:It is generally accepted that in living kidney donor nephrectomy for transplantation, the donor should remain with the larger kidney volume if possible. It has…2013 American Transplant Congress
Psychiatric Outcomes of Liver Transplantation after Acetaminophen Overdose
Psychiatry and Psychology, Mayo Clinic, Rochester, MN
Acetaminophen overdose is the leading cause of acute liver failure in the United States. A substantial proportion of these patients survive with conservative treatment. Liver…2013 American Transplant Congress
Risk Factors for Graft Loss Due to BK Nephropathy: A Paired Kidney Analysis
The purpose of this case control study was to identify risk factors for transplant failure due to BK Nephropathy (BK).Using SRTR data from 1987-2011, we…
American Transplant Congress abstracts